Currently, there are no licensed vaccines or therapeutics available to combat Zika, researchers said.
The vaccine developed by researchers from Arizona State University (ASU) in the US works against a part of a Zika viral protein, called DIII, that plays a key role for the virus to infect people.
"All flaviviruses have the envelope protein on the outside part of the virus. It has three domains," said Qiang Chen, a scientist at ASU.
"The domain III has a unique stretch of DNA for the Zika virus, and we exploited this to generate a robust and protective immune response that is unique for Zika," said Chen, who led the research published in the journal Scientific Reports.
The team then performed immunisation experiments in mice, which induced antibody and cellular immune responses that have been shown to confer 100 per cent protection against multiple Zika virus strains in mice.
The team's protein-based vaccine uses the smallest and most unique part of the Zika virus that can still elicit a potent and robust immune response.
"In our approach, we make what we call a pseudovirus. It is a fake virus. The pseudovirus displays only the DIII part of the envelope protein on the surface," said Chen.
The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the Americas.
It struck great fear in pregnant women, as babies born with severe brain birth defects quickly overburdened hospitals and public health care systems.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
